Skip to main content
SpringerLink
Log in

Acute Kidney Injury and Renal Replacement Therapy in Immunocompromised Children

  • Chapter
  • First Online:
Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient

  • 807 Accesses

Abstract

Acute kidney injury (AKI) occurs commonly in immunocompromised children with cancer and has a significant impact on morbidity and mortality. Early identification of patients at risk is of critical importance so that targeted and effective management can be implemented. While therapy for AKI remains mainly supportive, recent progress in the science of AKI has allowed for advancement in the diagnosis and treatment of AKI. Caring for critically ill children with AKI requires a multidisciplinary approach with input from all practitioners. With further innovation in the application of current therapies and the development of new treatment modalities, survival for children with cancer will continue to improve.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kaddourah A, et al. Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med. 2017;376(1):11–20.

    Article  Google Scholar 

  2. Kellum JA, et al. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care. 2002;8(6):509–14.

    Article  Google Scholar 

  3. Akcan-Arikan A, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71(10):1028–35.

    Article  CAS  Google Scholar 

  4. Mehta RL, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.

    Article  Google Scholar 

  5. Alkandari O, et al. Acute kidney injury is an independent risk factor for pediatric intensive care unit mortality, longer length of stay and prolonged mechanical ventilation in critically ill children: a two-center retrospective cohort study. Crit Care. 2011;15(3):R146.

    Article  Google Scholar 

  6. Zappitelli M, et al. A small post-operative rise in serum creatinine predicts acute kidney injury in children undergoing cardiac surgery. Kidney Int. 2009;76(8):885–92.

    Article  CAS  Google Scholar 

  7. Sanchez-Pinto LN, et al. Association between progression and improvement of acute kidney injury and mortality in critically ill children. Pediatr Crit Care Med. 2015;16(8):703–10.

    Article  Google Scholar 

  8. Devarajan P. Emerging biomarkers of acute kidney injury. In: Ronco C, Bellomo R, Kellum JA, editors. Acute kidney injury. Basel: Karger Publishers; 2007. p. 203–12.

    Chapter  Google Scholar 

  9. Samuels J, et al. Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality in critically ill patients with cancer. Support Care Cancer. 2011;19(10):1527–32.

    Article  Google Scholar 

  10. Chertow GM, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–70.

    Article  Google Scholar 

  11. Volpon LC, Sugo EK, Carlotti AP. Diagnostic and prognostic value of serum cystatin C in critically ill children with acute kidney injury. Pediatr Crit Care Med. 2015;16(5):e125–31.

    Article  Google Scholar 

  12. Safdar OY, et al. Serum cystatin is a useful marker for the diagnosis of acute kidney injury in critically ill children: prospective cohort study. BMC Nephrol. 2016;17(1):130.

    Article  Google Scholar 

  13. Inker LA, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–9.

    Article  CAS  Google Scholar 

  14. Al-Tonbary YA, et al. Pretreatment cystatin C in children with malignancy: can it predict chemotherapy-induced glomerular filtration rate reduction during the induction phase? J Pediatr Hematol Oncol. 2004;26(6):336–41.

    Article  Google Scholar 

  15. Barnfield MC, et al. Cystatin C in assessment of glomerular filtration rate in children and young adults suffering from cancer. Nucl Med Commun. 2013;34(6):609–14.

    Article  CAS  Google Scholar 

  16. Whiting P, et al. Accuracy of cystatin C for the detection of abnormal renal function in children undergoing chemotherapy for malignancy: a systematic review using individual patient data. Support Care Cancer. 2017:1–10.

    Google Scholar 

  17. Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol. 2008;23(12):2151.

    Article  Google Scholar 

  18. Sterling M, et al. Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy. Pediatr Blood Cancer. 2017;64(10)

    Article  Google Scholar 

  19. Basu RK, et al. Incorporation of biomarkers with the renal angina index for prediction of severe AKI in critically ill children. Clin J Am Soc Nephrol. 2014;9(4):654–62.

    Article  Google Scholar 

  20. Bihorac A, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med. 2014;189(8):932–9.

    Article  CAS  Google Scholar 

  21. Meersch M, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery. PLoS One. 2014;9(10):e110865.

    Article  Google Scholar 

  22. Fortenberry JD, Paden ML, Goldstein SL. Acute kidney injury in children: an update on diagnosis and treatment. Pediatr Clin. 2013;60(3):669–88.

    Article  Google Scholar 

  23. Plötz FB, et al. Effect of acute renal failure on outcome in children with severe septic shock. Pediatr Nephrol. 2005;20(8):1177–81.

    Article  Google Scholar 

  24. Michael M, Kuehnle I, Goldstein SL. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol. 2004;19(1):91–5.

    Article  Google Scholar 

  25. Sutherland SM, et al. AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions. Clin J Am Soc Nephrol. 2015;10(4):554–61.

    Article  Google Scholar 

  26. Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis. 2005;45(1):96–101.

    Article  Google Scholar 

  27. Koh K-N, et al. Acute kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation: incidence, risk factors, and outcomes. Biol Blood Marrow Transplant. 2018;24(4):758–64.

    Article  Google Scholar 

  28. Hingorani S. Renal complications of hematopoietic-cell transplantation. N Engl J Med. 2016;374(23):2256–67.

    Article  Google Scholar 

  29. Selewski DT, et al. Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population. Intensive Care Med. 2014;40(10):1481–8.

    Article  Google Scholar 

  30. Raina R, et al. Hematopoietic stem cell transplantation and acute kidney injury in children: A comprehensive review. Pediatr Transplant. 2017;21(4):e12935.

    Article  Google Scholar 

  31. Krishnappa V, et al. Acute kidney injury in hematopoietic stem cell transplantation: a review. Int J Nephrol. 2016;2016:5163789.

    Article  Google Scholar 

  32. Mori J, et al. Risk assessment for acute kidney injury after allogeneic hematopoietic stem cell transplantation based on Acute Kidney Injury Network criteria. Intern Med. 2012;51(16):2105–10.

    Article  Google Scholar 

  33. Changsirikulchai S, et al. Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol. 2009;4(2):345–53.

    Article  Google Scholar 

  34. Laskin BL, et al. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation–associated thrombotic microangiopathy. Blood. 2011;118(6):1452–62.

    Article  CAS  Google Scholar 

  35. Du Plessis L, Rassekh SR, Mammen C. High incidence of acute kidney injury during chemotherapy for childhood acute myeloid leukemia. Pediatr Blood Cancer. 2018;65(4):e26915.

    Article  Google Scholar 

  36. Fitzgerald JC, et al. Acute kidney injury in pediatric severe sepsis: an independent risk factor for death and new disability. Crit Care Med. 2016;44(12):2241–50.

    Article  Google Scholar 

  37. Foland JA, et al. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med. 2004;32(8):1771–6.

    Article  Google Scholar 

  38. Arikan AA, et al. Fluid overload is associated with impaired oxygenation and morbidity in critically ill children. Pediatr Crit Care Med. 2012;13(3):253–8.

    Article  Google Scholar 

  39. Varghese SA, et al. Identification of diagnostic urinary biomarkers for acute kidney injury. J Investig Med. 2010;58(4):612–20.

    Article  CAS  Google Scholar 

  40. Arikan AA, et al. Resuscitation bundle in pediatric shock decreases acute kidney injury and improves outcomes. J Pediatr. 2015;167(6):1301–1305. e1.

    Article  Google Scholar 

  41. Tumlin JA, et al. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis. 2005;46(1):26–34.

    Article  CAS  Google Scholar 

  42. Goldstein SL, et al. Outcome in children receiving continuous venovenous hemofiltration. Pediatrics. 2001;107(6):1309–12.

    Article  CAS  Google Scholar 

  43. Modem V, et al. Timing of continuous renal replacement therapy and mortality in critically ill children. Crit Care Med. 2014;42(4):943–53.

    Article  CAS  Google Scholar 

  44. Choi SJ, et al. Factors associated with mortality in continuous renal replacement therapy for pediatric patients with acute kidney injury. Pediatr Crit Care Med. 2017;18(2):e56–61.

    Article  Google Scholar 

  45. Goldstein SL, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int. 2005;67(2):653–8.

    Article  Google Scholar 

  46. Hackbarth R, et al. The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry. Int J Artif Organs. 2007;30(12):1116–21.

    Article  CAS  Google Scholar 

  47. Fernández SN, et al. Citrate anticoagulation for CRRT in children: comparison with heparin. Biomed Res Int. 2014;2014:1–7.

    Google Scholar 

  48. Wu M-Y, et al. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012;59(6):810–8.

    Article  CAS  Google Scholar 

  49. Asín-Prieto E, et al. Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis. J Antimicrob Chemother. 2013;69(1):180–9.

    Article  Google Scholar 

  50. Chaijamorn W, Wanakamanee U. Pharmacokinetics of vancomycin in critically ill patients undergoing continuous venovenous haemodialysis. Int J Antimicrob Agents. 2014;44(4):367–8.

    Article  CAS  Google Scholar 

  51. Veltri MA, et al. Drug dosing during intermittent hemodialysis and continuous renal replacement therapy. Pediatr Drugs. 2004;6(1):45–65.

    Article  Google Scholar 

  52. Sgambat K, Moudgil A. Carnitine deficiency in children receiving continuous renal replacement therapy. Hemodial Int. 2016;20(1):63–7.

    Article  Google Scholar 

  53. Knijnenburg SL, et al. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Libr. 2013;(10):1–197.

    Google Scholar 

  54. Mulder RL, et al. Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study. Cancer Epidemiol Prev Biomarkers. 2013;22(10):1736–46.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Renal Section, Texas Children’s Hospital/Baylor College of Medicine, Houston, TX, USA

    Joseph Angelo

  2. Renal Section, Critical Care Section, Texas Children’s Hospital/Baylor College of Medicine, Houston, TX, USA

    Ayse A. Arikan

Authors
  1. Joseph Angelo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayse A. Arikan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph Angelo .

Editor information

Editors and Affiliations

  1. Pediatric Hematology-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

    Christine N. Duncan

  2. Children’s Hospital of Wisconsin-Milwaukee, Medical College of Wisconsin, Milwaukee, WI, USA

    Julie-An M. Talano

  3. Department of Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN, USA

    Jennifer A. McArthur

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Angelo, J., Arikan, A.A. (2019). Acute Kidney Injury and Renal Replacement Therapy in Immunocompromised Children. In: Duncan, C., Talano, JA., McArthur, J. (eds) Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient. Springer, Cham. https://doi.org/10.1007/978-3-030-01322-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-01322-6_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-01321-9

  • Online ISBN: 978-3-030-01322-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation